Gina Mazzariello - 22 Feb 2022 Form 3 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Signature
/s/ Joshua B. Cohen, as Attorney in Fact
Issuer symbol
AMLX
Transactions as of
22 Feb 2022
Net transactions value
$0
Form type
3
Filing time
28 Feb 2022, 16:02:45 UTC
Next filing
28 Feb 2023

No securities are beneficially owned.